| Trial ID: | L1030 |
| Source ID: | NCT00528788
|
| Associated Drug: |
Doxercalciferol
|
| Title: |
How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00528788/results
|
| Conditions: |
Hyperparathyroidism, Secondary|Kidney Failure, Chronic
|
| Interventions: |
DRUG: doxercalciferol
|
| Outcome Measures: |
Primary: Change in Endothelial Cell Function, Endothelial cell function was assessed by performing flow mediated vasodilatation testing in a vascular laboratory prior to receiving doxercalciferol (either 2 mcg or 4 mcg 3 times per week at hemodialysis) and then after receiving the drug for 30 days., 1 month |
|
| Sponsor/Collaborators: |
Sponsor: Duke University | Collaborators: Genzyme, a Sanofi Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-09
|
| Completion Date: |
2012-08
|
| Results First Posted: |
2014-04-14
|
| Last Update Posted: |
2016-01-22
|
| Locations: |
Duke University Medical Center Dialysis Unit, Durham, North Carolina, 27705, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00528788
|
